A Positive TB Skin Test Doesn't Mean You Have TB, But Your Risk Profile Decides What It Does Mean
So the same positive result can mean almost nothing or something quite serious, depending entirely on who you are. That makes the context around your result far more important than the result itself.
What "Positive" Actually Tells You
A positive TST most often reflects latent TB infection, meaning the bacteria are present in your body but dormant. You aren't sick, you aren't contagious, and you may never be. The test measures your immune system's memory of exposure, not whether the bacteria are actively causing harm right now.
The interpretation hinges on three things: the size of the induration (the firm bump, not the redness), your risk factors, and whether you've had a BCG vaccination. None of these factors work in isolation. A 12 mm result in someone with no exposure history and a childhood BCG vaccine means something very different from the same result in a recent contact of an active TB case.
The Risk Gap Between Low-Risk and High-Risk Groups Is Enormous
This is where the numbers get striking. For the general population with a TST of 10 mm or more and no treatment, active TB develops at a rate of about 0.3 per 1,000 person-years. That's a fraction of a percent annually.
For higher-risk groups, the picture changes dramatically:
| Risk Category | Approximate Annual TB Incidence |
|---|---|
| General population, TST ≥10 mm | ~0.3 per 1,000 person-years |
| Higher-risk groups (contacts, HIV, dialysis, silicosis, immigrants, prisoners) | 8–27 per 1,000 person-years |
That's roughly 27 to 90 times higher in the most vulnerable groups. Web-based risk calculators exist that combine your induration size, medical conditions, and chest X-ray findings to estimate both your annual and lifetime risk of progression. These tools can make a vague positive result far more personally meaningful.
A Test That's Right Most of the Time, But Not All of the Time
The TST is a useful screening tool, but it's far from perfect. Its accuracy varies meaningfully by setting and cutoff used.
| Performance Measure | Range |
|---|---|
| Sensitivity (ability to catch true infection) | ~60–75% |
| Specificity (ability to avoid false alarms) | ~57–89% |
That specificity range is worth pausing on. At the lower end, nearly half of positive results could be false positives. At the higher end, the test performs much better. The cutoff threshold your clinician uses (5 mm, 10 mm, or 15 mm) shifts the balance between catching infections and avoiding false alarms.
The BCG Vaccine Complication
If you received the BCG vaccine, your positive TST may not mean what it seems. But how much it skews the result depends on when you got the vaccine.
- BCG at birth, more than 10 years ago: The effect on TST results is small. A positive test in this scenario is more likely to reflect true TB exposure.
- BCG given after infancy: The effect is larger and more persistent, making false positives more of a concern.
- BCG-vaccinated children: Accuracy is modest. Using a higher cutoff of 15 mm or more improves specificity but catches fewer true infections.
The common assumption that "my BCG vaccine explains my positive test" is sometimes true, but often overstated, particularly if the vaccine was given at birth and a decade or more has passed.
When a Negative Result Lies
A negative TST can offer false reassurance in people whose immune systems are compromised. Conditions that increase the chance of a falsely negative result include:
- HIV infection
- Steroid use
- Renal failure
- Older age
In these groups, a negative test does not reliably exclude infection. The immune system may simply be too suppressed to mount the skin reaction the test depends on. If you fall into a high-risk category and test negative, that result deserves skepticism rather than relief.
Newer Tests That Sidestep the BCG Problem
IGRAs (interferon-gamma release assays, which are blood tests) and newer skin tests based on specific TB proteins tend to be more specific than the traditional TST. They are also less affected by BCG vaccination, which means fewer false positives in vaccinated populations. In head-to-head comparisons, these newer tests come back positive less frequently than the TST in the same individuals, suggesting the TST overcounts in some groups.
The research doesn't detail whether these newer tests are universally available or preferred in all settings, but they represent a meaningful upgrade in specificity for people whose BCG history clouds the picture.
Turning Your Result Into a Decision
A positive TB skin test is a starting point, not a diagnosis. What you do next depends on where you fall on the risk spectrum.
- Low-risk, no known TB contacts, childhood BCG: Your annual risk of progression is very low. A chest X-ray and possibly an IGRA to confirm the result is a reasonable path.
- Higher-risk (close contact with active TB, HIV, immunosuppression, dialysis, recent immigration from a high-burden area): The progression risk is meaningfully higher, in the range of 8 to 27 per 1,000 person-years. Preventive treatment becomes a serious consideration.
- Immunosuppressed with a negative test: Don't assume you're clear. The test may have missed a real infection.
The size of the induration, your medical history, your exposure history, and your vaccination timeline all feed into the interpretation. This is genuinely one of those situations where the same lab result warrants different responses in different people, and a clinician who knows your full picture is the right person to help you make the call.
